Business News

HRV Pharma bets ₹150 crore on peptides, high-potency oncology APIs

Tuesday, September 8, 2026 - 11:10
0 0
HRV Pharma bets ₹150 crore on peptides, high-potency oncology APIs
The investments mark a shift in HRV’s seven-year-old business model—from using available manufacturing capacity to underwriting specialised capacity for products it owns and commercializes

Read More
Previous Article

Mint Explainer | The post-Tim Cook Apple: Can John Ternus fill the big shoes?

Next Article

Arnya, IPO-bound Casagrand form ₹750 cr south India-focused residential plat...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

US says Russia, Ukraine to let civilians leave war-torn area

US says Russia, Ukraine to let civilians leave war-t...

Saturday, October 24, 2026
0
1
PGTI, Essar partner to launch new annual tournament on India’s professional golf calendar

PGTI, Essar partner to launch new annual tournament ...

Saturday, October 24, 2026
0
1
SC holds voters can prosecute candidates for concealing information

SC holds voters can prosecute candidates for conceal...

Saturday, October 24, 2026
0
1
Chennai airport ATF tax cut to 16% from 29%; rate slashed to 1% for other TN airports

Chennai airport ATF tax cut to 16% from 29%; rate sl...

Saturday, October 24, 2026
0
0
Courts cannot be unmindful when precious water bodies remain unprotected: SC

Courts cannot be unmindful when precious water bodie...

Saturday, October 24, 2026
0
1
Government asks industry bodies to tighten certification checks, conduct regular cybersecurity audits

Government asks industry bodies to tighten certifica...

Saturday, October 24, 2026
0
1

Comments (0)

User